Hedge funds boost stakes in Dyne Therapeutics and TTM Technologies in Q1

hedge fund stake increase Dyne Therapeutics TTM Technologies Q1 2024 13F filings institutional ownership

During the first quarter, several hedge funds and institutional investors increased their holdings in two U.S.-listed companies. Rock Springs Capital Management raised its stake in Dyne Therapeutics to 972,198 shares, about 0.59% of the company and valued at roughly $17.6 million. Other investors such as Quantinno Capital Management, Orbimed Advisors, Renaissance Technologies, Dimensional Fund Advisors and the Swiss National Bank also expanded their positions, collectively bringing institutional ownership of Dyne to about 96.7%.

Rokos Capital Management added a new position in TTM Technologies, purchasing 133,769 shares for around $13 million, representing roughly 0.13% of the firm. Parallel Advisors grew its stake by 36.2% in Q1, while several other investors, including Kestra Advisory Services, Truvestments Capital, Rakuten Securities and Danske Bank, acquired modest new positions in the fourth quarter. Institutional investors now own about 95.8% of TTM Technologies.

Entities: Dyne Therapeutics, Inc. · Institutional investors · MP Materials Corp. · Rock Springs Capital Management LP · Rokos Capital Management LLP · TTM Technologies, Inc.

Claims

What the coverage asserts, and how well corroborated each claim is across sources.

[○ 1 SOURCE] Institutional investors own approximately 96.68% of Dyne Therapeutics’ stock. (d1a1c957-f1be-4f63-a5e8-2d094d44136c)
[○ 1 SOURCE] Rock Springs Capital Management’s stake represented about 0.59% of Dyne Therapeutics, worth $17.6 million. (d1a1c957-f1be-4f63-a5e8-2d094d44136c)
[○ 1 SOURCE] Rokos Capital Management bought 133,769 shares of TTM Technologies valued at about $13.0 million, representing roughly 0.13% of the company. (2632c138-f418-4d8a-99b8-1d86a1e6ac76)
[○ 1 SOURCE] Parallel Advisors increased its stake in TTM Technologies by 36.2% in Q1, holding 327 shares valued at $32,000. (2632c138-f418-4d8a-99b8-1d86a1e6ac76)
[○ 1 SOURCE] Institutional investors own about 95.79% of TTM Technologies’ stock. (2632c138-f418-4d8a-99b8-1d86a1e6ac76)
[○ 1 SOURCE] Rock Springs Capital Management owned 972,198 shares of Dyne Therapeutics after acquiring 59,243 shares in Q1. (d1a1c957-f1be-4f63-a5e8-2d094d44136c)